fingolimod hydrochloride has been researched along with psychosine in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (psychosine) | Trials (psychosine) | Recent Studies (post-2010) (psychosine) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 367 | 1 | 152 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dev, KK; O'Sullivan, C | 1 |
1 other study(ies) available for fingolimod hydrochloride and psychosine
| Article | Year |
|---|---|
Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling.
Topics: Animals; Apoptosis; Astrocytes; Demyelinating Diseases; Fingolimod Hydrochloride; Humans; Leukodystrophy, Globoid Cell; Lipopolysaccharides; Lysophospholipids; Mice; Microscopy, Fluorescence; Psychosine; Rats; Signal Transduction; Sphingosine | 2015 |